BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9191186)

  • 21. Major role for CD8 T cells in the protection against Toxoplasma gondii following dendritic cell vaccination.
    Guiton R; Zagani R; Dimier-Poisson I
    Parasite Immunol; 2009 Oct; 31(10):631-40. PubMed ID: 19751475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal study of the specific humoral and cellular response to Toxoplasma gondii in a patient with acquired toxoplasmosis.
    Derouin F; Rabian-Herzog C; Sulahian A
    J Clin Lab Immunol; 1989 Oct; 30(2):97-102. PubMed ID: 2641536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low levels of natural killer cells in pregnant women transmitting Toxoplasma gondii.
    Nigro G; Piazze J; Paesano R; Mango T; Provvedi S; Capuano O; Pollastrini L
    Prenat Diagn; 1999 May; 19(5):401-4. PubMed ID: 10360506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cellular immune response in mice vaccinated with uv-attenuated Toxoplasma gondii ZS1 strain trophozoites].
    Lu F; Zheng H; Guo H; Chen G
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(6):384-6. PubMed ID: 12563744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations.
    Sanders KL; Fox BA; Bzik DJ
    Cancer Immunol Res; 2015 Aug; 3(8):891-901. PubMed ID: 25804437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
    Khan IA; Casciotti L
    J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection.
    Hwang S; Khan IA
    Semin Immunopathol; 2015 May; 37(3):271-9. PubMed ID: 25944514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host immune responses to Toxoplasma gondii.
    Sasai M; Pradipta A; Yamamoto M
    Int Immunol; 2018 Mar; 30(3):113-119. PubMed ID: 29408976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunobiology of the innate response to Toxoplasma gondii.
    Miller CM; Boulter NR; Ikin RJ; Smith NC
    Int J Parasitol; 2009 Jan; 39(1):23-39. PubMed ID: 18775432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preimmune resistance to Toxoplasma gondii in aged and young adult mice.
    Johnson LL; Gibson GW; Sayles PC
    J Parasitol; 1995 Dec; 81(6):894-9. PubMed ID: 8544060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine asialo GM1+CD8+ T cells as novel interleukin-12-responsive killer T cell precursors.
    Lee U; Santa K; Habu S; Nishimura T
    Jpn J Cancer Res; 1996 May; 87(5):429-32. PubMed ID: 8641977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of symptomatic human infection with Toxoplasma gondii with imbalance of monocytes and antigen-specific T cell subsets.
    Sklenar I; Jones TC; Alkan S; Erb P
    J Infect Dis; 1986 Feb; 153(2):315-24. PubMed ID: 2935581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii.
    Gazzinelli RT; Amichay D; Sharton-Kersten T; Grunwald E; Farber JM; Sher A
    Curr Top Microbiol Immunol; 1996; 219():127-39. PubMed ID: 8791695
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel B-2 suppressor cell regulating susceptibility/resistance of mice to Toxoplasma gondii infection.
    Mun HS; Aosai F; Fang H; Piao LX; Winn T; Norose K; Yano A
    Microbiol Immunol; 2005; 49(9):853-8. PubMed ID: 16172540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Peripheral blood lymphocytes T gammadelta in children with acute acquired toxoplasmosis].
    Kmieć K; Woźniakowska-Gesicka T
    Wiad Parazytol; 2001; 47 Suppl 1():45-9. PubMed ID: 16897951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.
    Dzierszinski F; Pepper M; Stumhofer JS; LaRosa DF; Wilson EH; Turka LA; Halonen SK; Hunter CA; Roos DS
    Infect Immun; 2007 Nov; 75(11):5200-9. PubMed ID: 17846116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function.
    Yap GS; Sher A
    Immunobiology; 1999 Dec; 201(2):240-7. PubMed ID: 10631573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of IFN-gamma-mediated expression of endothelial VCAM-1 on recruitment of CD8+ T cells into the brain during chronic infection with Toxoplasma gondii.
    Wang X; Michie SA; Xu B; Suzuki Y
    J Interferon Cytokine Res; 2007 Apr; 27(4):329-38. PubMed ID: 17477820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection.
    Mahamed DA; Toussaint LE; Bynoe MS
    Infect Immun; 2015 Feb; 83(2):721-9. PubMed ID: 25452548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of human T lymphocytes obtained from Toxoplasma gondii-seronegative persons by proteins derived from T. gondii.
    Purner MB; Berens RL; Tomavo S; Lecordier L; Cesbron-Delauw MF; Kotzin BL; Curiel TJ
    J Infect Dis; 1998 Mar; 177(3):746-53. PubMed ID: 9498457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.